Log in to search using one of your social media accounts:

 

Statins May Help People With COPD Live Longer

Deaths from lung - related causes were reduced by as much as 45 percent, study suggests
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Pharmacy, Pulmonology, News, Source Type: news

Related Links:

Statin exposure associated with lower all - cause, pulmonary mortality
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news
Deaths from lung-related causes were reduced by as much as 45 percent, study suggests
Source: WebMD Health - Category: Consumer Health News Source Type: news
Deaths from lung-related causes were reduced by as much as 45 percent, study suggests Source: HealthDay Related MedlinePlus Pages: COPD, Statins
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news
FRIDAY, Sept. 8, 2017 -- Drugs known as statins may have benefits beyond lowering " bad " LDL cholesterol levels. A new study suggests people with chronic lung disease who take these drugs may extend their survival. The study from Canada included...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
CONCLUSIONS: The findings from this systematic review suggest a role for statins in COPD patients with coexisting cardiovascular disease, evidence of increased systemic inflammation, or hyperlipidemia, in terms of improving exercise tolerance and pulmonary function. These findings need to be confirmed by randomized controlled trials specifically designed to test this hypothesis and identify appropriate patients for statin use. PMID: 28847550 [PubMed - as supplied by publisher]
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
Discussions of radical life extension, technological acceleration, and artificial general intelligence were far more fringe concerns back then than is now the case, but this growth in awareness isn't a coincidence. Visions slowly become reality because people work to make that happen. Technological progress is not accidental: it is led by our desires. I should say that de Magalhães is here generous in not passing judgement on the value (or lack thereof) of most of the various ventures and classes of approach he surveys. But some approaches are definitely better than others, and to my eyes one the principal ch...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Conclusion This study aimed to see whether beta blockers reduce mortality in people who've had a heart attack but who don't have heart failure or systolic dysfunction. It found no difference between those who were and those who were not given beta-blockers on discharge from hospital. The authors say this adds to the evidence that routine prescription of beta blockers might not be needed for patients without heart failure following a heart attack. Current UK guidelines recommend all people who have had a heart attack take beta blockers for at least one year to reduce risk of recurrent events. Only people with heart failure ...
Source: NHS News Feed - Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news
Our brains can easily fool us. No experienced doctor would deny the power of the placebo effect. Today I want to discuss the nocebo effect, which occurs when negative expectations of something causes it to have a more negative effect than it otherwise would. Drugs can exert a strong nocebo effect. If your brain thinks you will have a side effect, you may actually get that effect. Nocebo brain trickery is relevant to statins. That’s why I used this wording in my last post: (Note the italics) The actual frequency of muscle symptoms is hotly debated. Randomized controlled trials (in which patients don’t know wheth...
Source: Dr John M - Category: Cardiology Authors: Source Type: blogs
CONCLUSIONS The presence of diabetes markedly increases the risk of 1-year adverse clinical outcomes in outpatients with CHF independent of multiple common risk factors. More effective and personalized treatment for diabetes should be considered in this particularly high-risk patient population.
Source: Diabetes Care - Category: Endocrinology Authors: Tags: Cardiovascular and Metabolic Risk Source Type: research
By AL LEWIS I’ve been quite vocal about supporting only wellness done for employees and not to them…but what if there could be a “conventional” wellness program – even including screening, HRAs etc. – that both you and I could love? People manage what’s measured and what’s paid for. If employers want people to stay healthy in the long run, why not measure and pay for health in the long run? Why not give people the incentive to stay healthy during their working years, instead of giving them the incentive to pretend to participate in programs of no interest, just to make a fe...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Source Type: blogs
More News: Cholesterol | Chronic Obstructive Pulmonary | Respiratory Medicine | Statin Therapy | Study